T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma
about
Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study.Immunomodulatory therapy for melanoma: ipilimumab and beyondFrequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab.
P2860
T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma
description
article
@en
im November 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2011
@uk
name
T-cell activation and maturati ...... limumab in metastatic melanoma
@en
T-cell activation and maturati ...... limumab in metastatic melanoma
@nl
type
label
T-cell activation and maturati ...... limumab in metastatic melanoma
@en
T-cell activation and maturati ...... limumab in metastatic melanoma
@nl
prefLabel
T-cell activation and maturati ...... limumab in metastatic melanoma
@en
T-cell activation and maturati ...... limumab in metastatic melanoma
@nl
P2093
P50
P356
P1476
T-cell activation and maturati ...... limumab in metastatic melanoma
@en
P2093
Francesco Agustoni
Gabrina Tragni
Giuseppe Di Tolla
Ilaria Bersani
Jeffrey S Weber
Valentina Colonna
P304
P356
10.1200/JCO.2011.36.5957
P407
P577
2011-10-11T00:00:00Z